cDC1-Targeted Gene Editing for Cancer Immunotherapy
Salva questo lavoro e mantieni la tua ricerca organizzata
Crea un account gratuito per salvare lavori, creare avvisi e tornare a questa inserzione dalla tua dashboard.
Continuando accetti i nostri Termini & Informativa sulla privacy.
Università degli Studi di Perugia invites applications for a Research Fellow to advance gene-targeting and genome-editing strategies aimed at selectively modulating conventional type 1 dendritic cells (cDC1) in cancer immunotherapy.
The project will cover design of regulatory-region targeting systems, vector engineering, and optimization of AhR targeting in cDC1, with analyses by molecular methods, flow cytometry and gene expression to evaluate efficiency and specificity.